Physician profile
Mark D Williams
NPI 1821484163
$3,902.65
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,789 · 2020: $407 · 2021: $1,121 · 2022: $458 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,641.04 | 2019 | |
| Stryker Corporation | $1,404.76 | 2019-2022 | |
| Depuy Synthes Sales INC. | $213.40 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $127.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $118.05 | 2020 | |
| Pacira Therapeutics, INC. | $116.24 | 2020 | |
| Kci USA, INC. | $88.96 | 2019-2021 | |
| Smith+Nephew, INC. | $84.05 | 2021 | |
| Acumed LLC | $31.23 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.43 | 2021 | |
| Zyla Life Sciences, INC. | $16.73 | 2020 | |
| Vistapharm, INC. | $16.35 | 2021 | |
| Baudax Bio INC. | $14.42 | 2021 | |
| Ethicon US, LLC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.